46 studies found for:    Acid Lipase Disease
Show Display Options
Rank Status Study
21 Completed Long-term Investigation of Resveratrol on Fat Metabolism in Obese Men With Nonalcoholic Fatty Liver Disease
Conditions: Obesity;   Nonalcoholic Fatty Liver Disease
Interventions: Dietary Supplement: Resveratrol;   Other: Placebo
22 Completed
Has Results
Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)
Condition: Human Immunodeficiency Virus Infection
Interventions: Drug: lopinavir/ritonavir (LPV/r);   Drug: emtricitabine/tenofovir disoproxil fumarate (FTC/TDF);   Drug: raltegravir (RAL)
23 Completed
Has Results
Drug-Drug Interaction - 3 Arm - Carboplatin/Paclitaxel, Dacarbazine
Condition: Advanced Melanoma
Interventions: Drug: Ipilimumab;   Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Dacarbazine
24 Recruiting Lovaza Mechanisms of Action
Condition: Moderate Hypertriglyceridemia.
Intervention: Dietary Supplement: Omega 3 fatty acid (Lovaza)
25 Active, not recruiting Comparison of rhBSSL With Placebo When Added to Infant Formula or Pasteurized Breast Milk During 4 Weeks of Treatment in Preterm Infants
Condition: Prevention of Growth Restriction
Interventions: Drug: rhBSSL (recombinant human bile-salt-stimulated lipase);   Drug: Placebo
26 Unknown  Following Lipectomy to Understand Adipose Tissue Re-accumulation
Conditions: Menopause;   Pre-menopause
Intervention: Procedure: Femoral lipectomy
27 Suspended Duration of Effect of Alipogene Tiparvovec Treatment, Which Was Administered in Other Studies
Condition: Hyperlipoproteinemia Type I
Intervention:
28 Recruiting Baby Observational and Nutritional Study
Conditions: Cystic Fibrosis;   Growth Failure;   Exocrine Pancreatic Insufficiency
Interventions: Drug: Pancrelipase 3000 USP units of lipase;   Drug: Pancrelipase 750 USP units of lipase
29 Unknown  Safety and Efficacy in LPL-Deficient Subjects of AMT-011, an Adeno-Associated Viral Vector Expressing Human Lipoprotein Lipase [S447X]
Condition: Familial Lipoprotein Lipase Deficiency
Interventions: Genetic: Alipogene Tiparvovec (AMT-011), Human LPL [S447X];   Drug: Mycophenolate mofetil;   Drug: cyclosporine
30 Completed Substrate Cycling in Energy Metabolism
Conditions: Burns;   Insulin Resistance
Intervention: Drug: fenofibrate
31 Suspended A Molecular Pharmacodynamic Dose-titration Trial of Conjugated Linoleic Acid (CLA; Clarinol®) in Patients With Advanced Solid Tumors
Condition: Advanced Solid Tumors
Interventions: Dietary Supplement: Conjugated Linoleic Acid;   Drug: Conjugated Linoleic Acid
32 Completed
Has Results
48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection
Condition: Infection, Human Immunodeficiency Virus I
Interventions: Drug: LEXIVA (GW433908);   Drug: Ritonavir
33 Active, not recruiting
Has Results
Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GW433908;   Drug: ritonavir
34 Unknown  Proof of Principle Trial to Determine if Nutritional Supplement Conjugated Linoleic Acid (CLA) Can Modulate the Lipogenic Pathway in Breast Cancer Tissue
Condition: Breast Cancer
Intervention: Drug: Conjugated Linoleic Acid (CLA)
35 Terminated
Has Results
A Study of LY2599506 in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Placebo;   Drug: LY2599506
36 Terminated
Has Results
A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: LY2599506;   Drug: Glyburide;   Drug: Placebo
37 Completed Comparative Effects of 2 Diets in Veterans With the Metabolic Syndrome
Condition: Metabolic Syndrome
Interventions: Dietary Supplement: MUFA MOVE! (Monounsaturated fatty enriched diet);   Dietary Supplement: PUFA MOVE! (Polyunsaturated fatty acid enriched diet)
38 Completed Efficacy and Safety of Human Lipoprotein Lipase (LPL)[S447X] Expressed by an Adeno-Associated Viral Vector in LPL-deficient Subjects
Condition: Familial Lipoprotein Lipase Deficiency
Interventions: Genetic: Alipogene Tiparvovec (AMT-011), Human LPL [S447X];   Drug: mycophenolate mofetil;   Drug: cyclosporine;   Drug: methylprednisolone
39 Completed Cross-over Study on Effect of Lipid Lowering by Acipimox on Cardiac and Skeletal Muscle Mitochondrial Function
Conditions: Diabetes Mellitus, Type 2;   Cardiomyopathy, Dilated
Interventions: Drug: Acipimox;   Drug: Cellulosum Mycrocryst
40 Completed
Has Results
Fat Perception in Humans (09-0873)
Condition: Obesity
Intervention:

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-46) Show next page of results
Indicates status has not been verified in more than two years